NEKTAR THERAPEUTICS
Pharmaceutical Preparations · 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
官方登记数据
0位关注者
1990成立于
关于 NEKTAR THERAPEUTICS
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
Source: Wikipedia
行业Pharmaceutical Preparations
总部455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
成立1990
状态营业中
专利1230 项专利
POLYMER ENGINEERED FORMS OF COLONY STIMULATING FACTOR-1WO2026064439A1 · 2026
Method for enhancing cellular immunotherapyAU2020252569B2 · 2026
关键数据
法律信息
| 法定名称 | NEKTAR THERAPEUTICS |
|---|---|
| SEC CIK | 906709在 SEC EDGAR 上查看 ↗ |
| EIN | 94-3134940 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA 94158
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面